Your browser doesn't support javascript.
Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic.
Patoulias, Dimitrios; Papadopoulos, Christodoulos; Boulmpou, Aristi; Doumas, Michael.
  • Patoulias D; Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.
  • Papadopoulos C; Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.
  • Boulmpou A; Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.
  • Doumas M; Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.
Diabetes Obes Metab ; 23(7): 1696-1700, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1132884

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / COVID-19 Type of study: Observational study / Prognostic study / Reviews Limits: Humans Language: English Journal: Diabetes Obes Metab Journal subject: Endocrinology / Metabolism Year: 2021 Document Type: Article Affiliation country: Dom.14359

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / COVID-19 Type of study: Observational study / Prognostic study / Reviews Limits: Humans Language: English Journal: Diabetes Obes Metab Journal subject: Endocrinology / Metabolism Year: 2021 Document Type: Article Affiliation country: Dom.14359